Portal de investigación
Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Hernandez, JM
- Martin, G
- Gutierrez, NC
- Ferro, MT
- Martinez-Climent, JA
- Luno, E
- Tormo, M
- Rayon, C
- Diaz-Mediavilla, J
- Gonzalez, M
- Gonzalez-San Miguel, JD
- Perez-Equiza, K
- Rivas, C
- Esteve, J
- Alvarez, MD
- Odriozola, J
- Ribera, JM
- PETHEMA Cooperative Grp
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0390-6078, 1592-8721
- Tipo:
- Article
- Páginas:
- 807-813
- PubMed:
- 11522536
- Factor de Impacto:
- 0,507 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
HAEMATOLOGICA FERRATA STORTI FOUNDATION
Citas Recibidas en Web of Science: 55
Documentos
- No hay documentos
Métricas
Filiaciones
Filiaciones no disponibles
Cita
Hernandez JM,Martin G,Gutierrez NC,CERVERA J,Ferro MT,CALASANZ MJ,Martinez JA,Luno E,Tormo M,Rayon C,Diaz J,Gonzalez M,Gonzalez JD,Perez K,Rivas C,Esteve J,Alvarez MD,Odriozola J,Ribera JM,SANZ MA,PETHEMA GRP. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA. Haematologica. 2001. 86. (8):p. 807-813. IF:3,216. (1).